Correlation Between Cyteir Therapeutics and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Cyteir Therapeutics and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cyteir Therapeutics and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cyteir Therapeutics and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Cyteir Therapeutics and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cyteir Therapeutics with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cyteir Therapeutics and Mineralys Therapeutics,.
Diversification Opportunities for Cyteir Therapeutics and Mineralys Therapeutics,
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Cyteir and Mineralys is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Cyteir Therapeutics and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Cyteir Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cyteir Therapeutics are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Cyteir Therapeutics i.e., Cyteir Therapeutics and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Cyteir Therapeutics and Mineralys Therapeutics,
Considering the 90-day investment horizon Cyteir Therapeutics is expected to generate 1.22 times more return on investment than Mineralys Therapeutics,. However, Cyteir Therapeutics is 1.22 times more volatile than Mineralys Therapeutics, Common. It trades about 0.11 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about 0.01 per unit of risk. If you would invest 136.00 in Cyteir Therapeutics on August 24, 2024 and sell it today you would earn a total of 140.00 from holding Cyteir Therapeutics or generate 102.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 35.03% |
| Values | Daily Returns |
Cyteir Therapeutics vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Cyteir Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Mineralys Therapeutics, |
Cyteir Therapeutics and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cyteir Therapeutics and Mineralys Therapeutics,
The main advantage of trading using opposite Cyteir Therapeutics and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cyteir Therapeutics position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Cyteir Therapeutics vs. Nuvation Bio | Cyteir Therapeutics vs. Foghorn Therapeutics | Cyteir Therapeutics vs. C4 Therapeutics | Cyteir Therapeutics vs. Prelude Therapeutics |
| Mineralys Therapeutics, vs. Integrated Drilling Equipment | Mineralys Therapeutics, vs. Xponential Fitness | Mineralys Therapeutics, vs. Lipocine | Mineralys Therapeutics, vs. Delek Drilling |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |